Key risks
- PE multiple of 68.83 is elevated, pricing in significant future growth; earnings disappointment would expose material downside.
- Operating margin compressed 550 basis points from 23.46% (Sep 2023) to 17.75% (Dec 2024), raising questions about cost control, pricing power, or product mix; verify root causes.
- Quarterly EPS swung between 37.52 and 52.79 over the past year, with Mar 2025 recorded at 0, indicating earnings lumpiness; assess whether this reflects timing or operational instability.
- Minimal foreign institutional ownership (0.05% FII) and concentrated promoter stake (75%) may limit liquidity and make the stock sensitive to promoter actions.
Generated analysis · source review pending